Do the meta-analyses provide a clean bill of health to the use of renin-angiotensin system inhibitors in COVID-19?

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journal › Letter

Original language	English
Journal	Clinical Infectious Diseases
DOIs	https://doi.org/10.1093/cid/ciaa1167
Publication status	Accepted/In press - 8 Aug 2020

Access to Document

10.1093/cid/ciaa1167Licence: Unspecified

Cite this

Kow, C. S., & Hasan, S. S. (Accepted/In press). Do the meta-analyses provide a clean bill of health to the use of renin-angiotensin system inhibitors in COVID-19? Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaa1167

@article{06d4e40075484dbcb67c2a31875c78db,

title = "Do the meta-analyses provide a clean bill of health to the use of renin-angiotensin system inhibitors in COVID-19?",

keywords = "Meta-analyses, Renin-angiotensin system inhibitors, COVID-19",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2020",

month = aug,

day = "8",

doi = "10.1093/cid/ciaa1167",

language = "English",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Do the meta-analyses provide a clean bill of health to the use of renin-angiotensin system inhibitors in COVID-19?

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2020/8/8

Y1 - 2020/8/8

KW - Meta-analyses

KW - Renin-angiotensin system inhibitors

KW - COVID-19

U2 - 10.1093/cid/ciaa1167

DO - 10.1093/cid/ciaa1167

M3 - Letter

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

ER -